Stock Comparison
CHE vs DVA
Chemed Corp and DaVita HealthCare Partners Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$6.15B
$13.93B
P/E (TTM)
25.3
20.9
Forward P/E
18.7
15.0
Price/Sales
2.4
1.0
Price/Book
7.1
21.6
EV/EBITDA
15.0
9.8
Dividend Yield
0.51%
—
Profitability
Net Margin
10.20%
5.65%
Operating Margin
12.90%
13.90%
Return on Equity
25.60%
81.00%
Return on Assets
12.80%
7.50%
Growth (YoY)
Revenue Growth
1.60%
6.00%
Earnings Growth
-0.40%
43.50%
Price & Risk
Beta
0.5
0.9
52-Week High
$505.98
$217.04
52-Week Low
$364.71
$101.00
Analyst Target
$446.50
$193.71
Compare CHE and DVA your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.